In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ...
Feb. 4, 2025 — A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited ...
Terns Pharmaceuticals, Inc., a biopharmaceutical company with a market capitalization of $397 million, disclosed the departure of their Chief Financial Officer (CFO), Mark Vignola, Ph.D., effective ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...